Logo image of KRUS

KURA SUSHI USA INC-CLASS A (KRUS) Stock Fundamental Analysis

NASDAQ:KRUS - Nasdaq - US5012701026 - Common Stock - Currency: USD

75.4  -1.7 (-2.2%)

After market: 75.4 0 (0%)

Fundamental Rating

4

Overall KRUS gets a fundamental rating of 4 out of 10. We evaluated KRUS against 133 industry peers in the Hotels, Restaurants & Leisure industry. No worries on liquidiy or solvency for KRUS as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, KRUS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

KRUS had negative earnings in the past year.
In the past year KRUS had a positive cash flow from operations.
In the past 5 years KRUS reported 4 times negative net income.
In multiple years KRUS reported negative operating cash flow during the last 5 years.
KRUS Yearly Net Income VS EBIT VS OCF VS FCFKRUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

The Return On Assets of KRUS (-2.56%) is worse than 71.43% of its industry peers.
With a Return On Equity value of -4.67%, KRUS perfoms like the industry average, outperforming 47.37% of the companies in the same industry.
Industry RankSector Rank
ROA -2.56%
ROE -4.67%
ROIC N/A
ROA(3y)-0.86%
ROA(5y)-4.62%
ROE(3y)-1.79%
ROE(5y)-10.96%
ROIC(3y)N/A
ROIC(5y)N/A
KRUS Yearly ROA, ROE, ROICKRUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

The Gross Margin of KRUS (19.24%) is worse than 86.47% of its industry peers.
KRUS's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for KRUS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.07%
GM growth 5Y-1.7%
KRUS Yearly Profit, Operating, Gross MarginsKRUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

8

2. Health

2.1 Basic Checks

KRUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, KRUS has more shares outstanding
KRUS has more shares outstanding than it did 5 years ago.
KRUS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
KRUS Yearly Shares OutstandingKRUS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
KRUS Yearly Total Debt VS Total AssetsKRUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

KRUS has an Altman-Z score of 3.60. This indicates that KRUS is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 3.60, KRUS belongs to the best of the industry, outperforming 81.95% of the companies in the same industry.
There is no outstanding debt for KRUS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.6
ROIC/WACCN/A
WACC9.21%
KRUS Yearly LT Debt VS Equity VS FCFKRUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

KRUS has a Current Ratio of 2.67. This indicates that KRUS is financially healthy and has no problem in meeting its short term obligations.
KRUS has a better Current ratio (2.67) than 92.48% of its industry peers.
A Quick Ratio of 2.60 indicates that KRUS has no problem at all paying its short term obligations.
The Quick ratio of KRUS (2.60) is better than 92.48% of its industry peers.
Industry RankSector Rank
Current Ratio 2.67
Quick Ratio 2.6
KRUS Yearly Current Assets VS Current LiabilitesKRUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for KRUS have decreased strongly by -585.71% in the last year.
KRUS shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.37%.
Measured over the past years, KRUS shows a very strong growth in Revenue. The Revenue has been growing by 29.94% on average per year.
EPS 1Y (TTM)-585.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.56%
Revenue 1Y (TTM)21.37%
Revenue growth 3Y54.18%
Revenue growth 5Y29.94%
Sales Q2Q%13.27%

3.2 Future

KRUS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.07% yearly.
The Revenue is expected to grow by 18.41% on average over the next years. This is quite good.
EPS Next Y65.67%
EPS Next 2Y44.31%
EPS Next 3Y32.85%
EPS Next 5Y21.07%
Revenue Next Year18.12%
Revenue Next 2Y18.52%
Revenue Next 3Y19.29%
Revenue Next 5Y18.41%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
KRUS Yearly Revenue VS EstimatesKRUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
KRUS Yearly EPS VS EstimatesKRUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

KRUS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 1250.15, which means the current valuation is very expensive for KRUS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of KRUS indicates a slightly more expensive valuation: KRUS is more expensive than 71.43% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of KRUS to the average of the S&P500 Index (22.06), we can say KRUS is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 1250.15
KRUS Price Earnings VS Forward Price EarningsKRUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600 800 1K

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, KRUS is valued more expensive than 84.21% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 557.95
KRUS Per share dataKRUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates KRUS does not grow enough to justify the current Price/Earnings ratio.
KRUS's earnings are expected to grow with 32.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.31%
EPS Next 3Y32.85%

More info and screens

0

5. Dividend

5.1 Amount

KRUS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KURA SUSHI USA INC-CLASS A

NASDAQ:KRUS (6/5/2025, 6:12:26 PM)

After market: 75.4 0 (0%)

75.4

-1.7 (-2.2%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)04-08 2025-04-08/amc
Earnings (Next)N/A N/A
Inst Owners77.87%
Inst Owner Change-3.71%
Ins Owners6.84%
Ins Owner Change1.1%
Market Cap911.59M
Analysts78.75
Price Target66.87 (-11.31%)
Short Float %25.36%
Short Ratio5.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)28.17%
Min EPS beat(2)-5.58%
Max EPS beat(2)61.93%
EPS beat(4)1
Avg EPS beat(4)-6629.19%
Min EPS beat(4)-26473.1%
Max EPS beat(4)61.93%
EPS beat(8)3
Avg EPS beat(8)-3341.92%
EPS beat(12)6
Avg EPS beat(12)-2194.36%
EPS beat(16)10
Avg EPS beat(16)-1641.39%
Revenue beat(2)1
Avg Revenue beat(2)0.2%
Min Revenue beat(2)-1.99%
Max Revenue beat(2)2.38%
Revenue beat(4)2
Avg Revenue beat(4)-0.2%
Min Revenue beat(4)-1.99%
Max Revenue beat(4)2.38%
Revenue beat(8)2
Avg Revenue beat(8)-1.23%
Revenue beat(12)4
Avg Revenue beat(12)-0.56%
Revenue beat(16)7
Avg Revenue beat(16)1.21%
PT rev (1m)1.72%
PT rev (3m)-42.05%
EPS NQ rev (1m)-106.92%
EPS NQ rev (3m)-105.31%
EPS NY rev (1m)-2357.1%
EPS NY rev (3m)-424.54%
Revenue NQ rev (1m)-0.42%
Revenue NQ rev (3m)-1.27%
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)-1.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1250.15
P/S 3.53
P/FCF N/A
P/OCF 50.6
P/B 4.05
P/tB 4.05
EV/EBITDA 557.95
EPS(TTM)-0.68
EYN/A
EPS(NY)0.06
Fwd EY0.08%
FCF(TTM)-2.28
FCFYN/A
OCF(TTM)1.49
OCFY1.98%
SpS21.38
BVpS18.61
TBVpS18.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.56%
ROE -4.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.24%
FCFM N/A
ROA(3y)-0.86%
ROA(5y)-4.62%
ROE(3y)-1.79%
ROE(5y)-10.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.07%
GM growth 5Y-1.7%
F-Score4
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 350.42%
Cap/Sales 17.63%
Interest Coverage N/A
Cash Conversion 1186.89%
Profit Quality N/A
Current Ratio 2.67
Quick Ratio 2.6
Altman-Z 3.6
F-Score4
WACC9.21%
ROIC/WACCN/A
Cap/Depr(3y)464%
Cap/Depr(5y)432.88%
Cap/Sales(3y)20.03%
Cap/Sales(5y)22.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-585.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-55.56%
EPS Next Y65.67%
EPS Next 2Y44.31%
EPS Next 3Y32.85%
EPS Next 5Y21.07%
Revenue 1Y (TTM)21.37%
Revenue growth 3Y54.18%
Revenue growth 5Y29.94%
Sales Q2Q%13.27%
Revenue Next Year18.12%
Revenue Next 2Y18.52%
Revenue Next 3Y19.29%
Revenue Next 5Y18.41%
EBIT growth 1Y-1058.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year394.88%
EBIT Next 3Y94.97%
EBIT Next 5Y56.86%
FCF growth 1Y-92.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.12%
OCF growth 3YN/A
OCF growth 5Y21.12%